In the context of real-world evidence, a registry is a collection of data on a particular disease, medical condition, or treatment that is recorded over time. A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention.
A registry is typically created to collect data on a particular population, such as patients with a specific medical condition or those who have been treated with a particular medication. The data collected in a registry may be observational or experimental, and can include demographic information, medical history, treatment information, and outcomes.
A registry-based study, on the other hand, is a research study that uses data from a registry to evaluate the safety or effectiveness of a particular treatment or medical intervention. In a registry-based study, researchers analyze the data collected in a registry to answer specific research questions, such as whether a particular treatment is effective in improving patient outcomes, or whether there are any safety concerns associated with a specific medication.
The main difference between a registry and a registry-based study is that a registry is a database of information, while a registry-based study is a research study that uses data from a registry. Registries can be used for a variety of purposes, including monitoring the safety and effectiveness of treatments, tracking disease incidence and prevalence, and identifying gaps in care. Registry-based studies are one way to use the data collected in a registry to generate new knowledge and insights about a particular disease or treatment.
Overall, both registries and registry-based studies are important tools for collecting and analyzing real-world evidence, and can provide valuable information to healthcare providers, patients, and researchers about the safety and effectiveness of medical interventions.
Share this story...
Real World Evidence (RWE) 101 – HIPAA
RWE 101 - HIPAA HIPAA (Health Insurance Portability and Accountability Act), enacted in 1996, is a federal law in the United States that establishes regulations for the protection of [...]
Real World Evidence (RWE) 101 – The Common Rule
RWE 101 - The Common Rule The Common Rule plays a significant role in the governance of observational studies. The Common Rule refers to a set of regulations and [...]
Real World Evidence (RWE) 101 – The Tuskegee Syphilis Study (the reason we have the Belmont Report and the Common Rule)
RWE 101 - The Tuskegee Syphilis Study (the reason we have the Belmont Report and the Common Rule) The Tuskegee Syphilis Study, conducted from 1932 to 1972, stands as [...]
Real World Evidence (RWE) 101 – Observational Study vs Non-Interventional Study
RWE 101 - Observational Study vs Non-Interventional Study In the context of real-world evidence (RWE), the terms "observational study" and "non-interventional study" are often used interchangeably to refer to [...]
Real World Evidence (RWE) 101 – Are Non-Interventional Studies Regulated?
RWE 101 - Are Non-Interventional Studies Regulated? Yes, non-interventional studies (NIS) are regulated. While the specific regulations and requirements may vary by country, there are generally guidelines and provisions [...]
Real World Evidence (RWE) 101 – Postmarket Requirements (PMR) vs Post-Authorisation Safety Studies (PASS)
RWE 101 - Postmarket Requirements (PMR) vs Post-Authorisation Safety Studies (PASS) In the context of real-world evidence (RWE) and regulatory frameworks, postmarket requirements (PMRs) and post-authorization safety studies (PASS) [...]







